![]()
|
|
||||||||
J. Biol. Chem., Vol. 279, Issue 25, 26726-26734, June 18, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

From the Department of Pathology, University of Washington, Seattle, Washington 98195
DNA and RNA polymerases share a core architecture composed of three structurally conserved motifs: A, B, and C. Although the amino acid sequences of these motifs are highly conserved between closely related organisms, variation across broader evolutionary distances suggests that only a few residues in each motif are indispensable for polymerase function. To test this, we constructed libraries of human immunodeficiency virus type-1 (HIV-1) containing random single amino acid replacements in motif B of reverse transcriptase (RT), and we used selection in culture to assess RT function. Despite the nearly absolute constancy of motif B in vivo, virus replicating in culture tolerated a range of conservative and nonconservative substitutions at 10 of the 11 amino acid positions examined. These included residues that are invariant across all retroviral subfamilies and highly conversed in diverse retroelements. Several mutants retained wild type infectivity, and serial passage experiments revealed replacements that were neutral or even beneficial to viral fitness. In addition, a number of the selected variants exhibited altered susceptibility to the nucleoside analog inhibitors AZT and 3TC. Taken together, these data indicate that HIV-1 tolerates a range of substitutions at conserved RT residues and that selection against slightly deleterious mutations (purifying selection) in vivo masks a large repertoire of viable phenotypic variants. This mutational flexibility likely contributes to HIV-1 evolution in response to changing selection pressures in infected individuals.
Received for publication, December 22, 2003 , and in revised form, March 1, 2004.
* This work was supported by National Institutes of Health Grants RO1 AI34834 (to B. P.) and F32 AI10139 (to R. S.) and by the University of Utah Undergraduate Research Opportunities Program (to D. A.).
To whom correspondence should be addressed: Dept. of Pathology, K-072 Health Sciences Bldg., Box 357705, 1959 N.E. Pacific St., Seattle, WA 98195-7705. Tel.: 206-616-5062; Fax: 206-543-3967; E-mail: bradp{at}u.washington.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
D. Hoffmann, J. Seebach, A. Cosma, F. D. Goebel, K. Strimmer, H. M. Schatzl, and V. Erfle Therapeutic vaccination reduces HIV sequence variability FASEB J, February 1, 2008; 22(2): 437 - 444. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Smith, G. S. Gottlieb, D. J. Anderson, C. L. Pyrak, and B. D. Preston Human Immunodeficiency Virus Types 1 and 2 Exhibit Comparable Sensitivities to Zidovudine and Other Nucleoside Analog Inhibitors In Vitro Antimicrob. Agents Chemother., January 1, 2008; 52(1): 329 - 332. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Smith, D. J. Anderson, and B. D. Preston Hypersusceptibility to Substrate Analogs Conferred by Mutations in Human Immunodeficiency Virus Type 1 Reverse Transcriptase J. Virol., July 15, 2006; 80(14): 7169 - 7178. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Allen, M. Altfeld, S. C. Geer, E. T. Kalife, C. Moore, K. M. O'Sullivan, I. DeSouza, M. E. Feeney, R. L. Eldridge, E. L. Maier, et al. Selective Escape from CD8+ T-Cell Responses Represents a Major Driving Force of Human Immunodeficiency Virus Type 1 (HIV-1) Sequence Diversity and Reveals Constraints on HIV-1 Evolution J. Virol., November 1, 2005; 79(21): 13239 - 13249. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |